[1] Van Gelder I C, Rienstra M, Bunting K V, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)[J]. Eur Heart J, 2024, 45(36): 3314-414.
[2] Clarnette J A, Brooks A G, Mahajan R, et al.Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis[J]. Europace, 2018, 20(Fi_3): f366-f76.
[3] Kim D T, Lai A C, Hwang C, et al.The ligament of Marshall: a structural analysis in human hearts with implications for atrial arrhythmias[J]. J Am Coll Cardiol, 2000, 36(4): 1324-7.
[4] He B, Wang X, Zhao F, et al.The ligament of Marshall and arrhythmias: A review[J]. Pacing Clin Electrophysiol, 2021, 44(5): 792-9.
[5] Vlachos K, Denis A, Takigawa M, et al.The role of Marshall bundle epicardial connections in atrial tachycardias after atrial fibrillation ablation[J]. Heart Rhythm, 2019, 16(9): 1341-7.
[6] Gillis K, O'neill L, Wielandts J Y, et al. Vein of Marshall Ethanol Infusion as First Step for Mitral Isthmus Linear Ablation[J]. JACC Clinical electrophysiology, 2022, 8(3): 367-76.
[7] Ge W L, Li T, Lu Y F, et al.Efficacy and feasibility of vein of Marshall ethanol infusion during persistent atrial fibrillation ablation: A systematic review and meta-analysis[J]. Clin Cardiol, 2024, 47(1): e24178.
[8] 中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会, 中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动:目前的认识和治疗建议(2021) %J 中华心律失常学杂志 %J Chinese Journal of Cardiac Arrhythmias [Z]. 2022: 15-88.10.3760/cma.j.cn113859-20211224-00264
[9] Mahida S, Sacher F, Derval N, et al.Science Linking Pulmonary Veins and Atrial Fibrillation[J]. Arrhythmia & electrophysiology review, 2015, 4(1): 40-3.
[10] Verma A, Jiang C Y, Betts T R, et al.Approaches to catheter ablation for persistent atrial fibrillation[J]. N Engl J Med, 2015, 372(19): 1812-22.
[11] He Z, Yang L, Bai M, et al.Feasibility, efficacy, and safety of ethanol infusion into the vein of Marshall for atrial fibrillation: A meta-analysis[J]. Pacing Clin Electrophysiol, 2021, 44(7): 1151-62.
[12] Li F, Sun J Y, Wu L D, et al.The Long-Term Outcomes of Ablation With Vein of Marshall Ethanol Infusion vs. Ablation Alone in Patients With Atrial Fibrillation: A Meta-Analysis[J]. Front Cardiovasc Med, 2022, 9: 871654.
[13] 赵亚楠, 王贺, 邱承杰, et al.心房重构、氧化应激在心房颤动发病中作用机制的研究进展 %J 山东医药[J]. 2018, 58(43): 96-9.
[14] Prapan N, Ratanasit N, Karaketklang K.Significant functional tricuspid regurgitation portends poor outcomes in patients with atrial fibrillation and preserved left ventricular ejection fraction[J]. BMC Cardiovasc Disord, 2020, 20(1): 433.
[15] Zhao L, Jiang W, Zhou L, et al.The role of valvular regurgitation in catheter ablation outcomes of patients with long-standing persistent atrial fibrillation[J]. Europace, 2014, 16(6): 848-54.
[16] Den Uijl D W, Delgado V, Bertini M, et al. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation[J]. Heart, 2011, 97(22): 1847-51.
[17] Wang Q, Zhuo C, Shang Y, et al.U-Shaped Relationship Between Left Atrium Size on Echocardiography and 1-Year Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation - Prognostic Value Study[J]. Circ J, 2019, 83(7): 1463-71.
[18] Demarchi A, Neumann L, Rordorf R, et al.Long-term outcome of catheter ablation for atrial fibrillation in patients with severe left atrial enlargement and reduced left ventricular ejection fraction[J]. Europace, 2021, 23(11): 1751-6.
[19] Hwang C, Wu T J, Doshi R N, et al.Vein of marshall cannulation for the analysis of electrical activity in patients with focal atrial fibrillation[J]. Circulation, 2000, 101(13): 1503-5.
[20] Patterson E, Lazzara R, Szabo B, et al.Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins[J]. J Am Coll Cardiol, 2006, 47(6): 1196-206.
[21] Liu X, Yan Q, Li H, et al.Ablation of ligament of Marshall attenuates atrial vulnerability to fibrillation induced by inferior left atrial fat pad stimulation in dogs[J]. J Cardiovasc Electrophysiol, 2010, 21(9): 1024-30.
[22] Dong J Z, Sang C H, Yu R H, et al.Prospective randomized comparison between a fixed '2C3L' approach vs. stepwise approach for catheter ablation of persistent atrial fibrillation[J]. Europace, 2015, 17(12): 1798-806.
[23] He B, Zhao F, Yu W, et al.Ethanol Infusion of Vein of Marshall for the Treatment of Persistent Atrial Fibrillation: The Basics and Clinical Practice[J]. J Cardiovasc Dev Dis, 2022, 9(8).
[24] Valderrábano M, Peterson L E, Swarup V, et al.Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial[J]. JAMA, 2020, 324(16): 1620-8.
[25] Lador A, Peterson L E, Swarup V, et al.Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial[J]. Heart Rhythm, 2021, 18(7): 1045-54.
[26] Derval N, Duchateau J, Denis A, et al.Marshall bundle elimination, Pulmonary vein isolation, and Line completion for ANatomical ablation of persistent atrial fibrillation (Marshall-PLAN): Prospective, single-center study[J]. Heart Rhythm, 2021, 18(4): 529-37.
[27] Sang C, Liu Q, Lai Y, et al.Pulmonary Vein Isolation With Optimized Linear Ablation vs Pulmonary Vein Isolation Alone for Persistent AF: The PROMPT-AF Randomized Clinical Trial[J]. JAMA, 2025, 333(5): 381-9.
[28] Lai Y, Liu X, Sang C, et al.Effectiveness of ethanol infusion into the vein of Marshall combined with a fixed anatomical ablation strategy (the "upgraded 2C3L" approach) for catheter ablation of persistent atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2021, 32(7): 1849-56.
[29] Annoura M, Ogawa M, Kumagai K, et al.Cholesterol paradox in patients with paroxysmal atrial fibrillation[J]. Cardiology, 1999, 92(1): 21-7.
[30] Li Z Z, Liu T, Huang Q, et al.Association Between Pre-Radiofrequency Catheter Ablation Serum Lipid Levels and Recurrence of Atrial Fibrillation in 412 Patients in Beijing, China: A Single-Center Study[J]. Med Sci Monit, 2023, 29: e938288.
[31] Shang Y, Chen N, Wang Q, et al.Blood lipid levels and recurrence of atrial fibrillation after radiofrequency catheter ablation: a prospective study[J]. J Interv Card Electrophysiol, 2020, 57(2): 221-31.
[32] Zou H, Huang Q, Huang Q, et al.L-shaped association of plasma low-density lipoprotein cholesterol with atrial fibrillation recurrence after catheter ablation: a prospective cohort study[J]. Sci Rep, 2024, 14(1): 28434. |
